Contact Us
Primary IR Contact |
Jenna Cohen Senior Director, Investor Relations Phone: 857-209-3147 Email: jcohen@blueprintmedicines.com |
|
Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.
Primary IR Contact |
Jenna Cohen Senior Director, Investor Relations Phone: 857-209-3147 Email: jcohen@blueprintmedicines.com |
|